Talacotuzumab (JNJ 56022473) is an IgG1 fully humanized CD123 neutralizing monoclonal antibody containing a modified Fc structure. Talacotuzumab has a high affinity for CD123, CD32b/c, CD16-158F and CD16-158V, with KD of 0.43 nM, 188 nM, 46 nM and 16.8 n
CAS Number:
[1826831-79-1]
Target:
CSL 362 , JNJ 56022473
* VAT and and shipping costs not included. Errors and price changes excepted